| Serial Number | 97869600 |
| Word Mark | INVEA |
| Filing Date | Monday, April 3, 2023 |
| Status | 647 - EXAMINERS AMENDMENT - MAILED |
| Status Date | Thursday, April 18, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical preparations and substances for the treatment of gastrointestinal and hepatobiliary diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders and diseases relating to the gut-brain axis, involving the central nervous system, enteric nervous system, immune system, gastrointestinal tract, and dermatology; chemical preparations for the treatment of inflammatory diseases and disorders, including the central nervous system, enteric nervous system, immune system, gastrointestinal tract and dermatologic diseases and disorders, including atopic dermatitis, chronic urticaria, and prurigo nodularis ; biological preparations for the treatment of inflammatory diseases and disorders, including the central nervous system, enteric nervous system, immune system, gastrointestinal tract and dermatologic diseases and disorders, including atopic dermatitis, chronic urticaria, and prurigo nodularis; Pharmaceutical preparations for the treatment of gastrointestinal and hepatobiliary diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and immune system-related disorders; Pharmaceutical preparations in the field of gastrointestinal and hepatobiliary diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and immune system-related disorders; all these goods/services excluding food supplements, dietetic food preparations and ingredients and other dietetic products |
| Goods and Services | Biochemical preparations for the treatment of inflammatory diseases and disorders, including the central nervous system, enteric nervous system, immune system, gastrointestinal tract and dermatologic diseases and disorders, including atopic dermatitis, chronic urticaria, and prurigo nodularis |
| Goods and Services | Pharmaceutical preparations in the field of gastrointestinal and hepatobiliary diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and immune system-related disorders; all these goods/services excluding food supplements, dietetic food preparations and ingredients and other dietetic products |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, April 17, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, April 26, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, April 26, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Invea Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Guilford, CT 06437 |
| Event Date | Event Description |
| Thursday, April 6, 2023 | NEW APPLICATION ENTERED |
| Wednesday, April 26, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, December 29, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, January 17, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, January 17, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 17, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, April 17, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 17, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 17, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, April 18, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, April 18, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, April 18, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, April 19, 2024 | ASSIGNED TO LIE |
| Wednesday, September 11, 2024 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Wednesday, September 11, 2024 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Friday, April 19, 2024 | EXAMINER'S AMENDMENT ENTERED |